Results for "diabetes mellitus"
Pancreatitis
** Pancreatitis is an inflammatory condition of the pancreas that can present as a sudden, severe episode (acute) or as a long‑standing, progressive disease (chronic), each with distinct symptoms, causes, and complications. **CONTENT:** ## Overview The **pancreas** is a deep‑lying, bean‑shaped organ situated behind the stomach. It serves two vital roles: an exocrine function that releases digestive enzymes (such as amylase, lipase, and proteases) into the duodenum, and an endocrine function that secretes hormones—including **insulin** and **glucagon**—into the bloodstream to regulate blood glucose. **Pancreatitis** occurs when these enzymes become activated within the pancreas itself, leading to autodigestion, inflammation, and tissue injury. Two clinical forms dominate the landscape. **Acute pancreatitis** develops rapidly, often within hours, and is characterized by intense upper‑abdominal pain that radiates to the back, nausea, vomiting, and sometimes fever. Most episodes resolve within a few days with supportive care, but severe cases can progress to necrosis, infection, or organ failure. **Chronic pancreatitis** evolves over months to years, marked by persistent pain, progressive loss of exocrine function (causing fatty stools, weight loss, and malabsorption) and endocrine failure, which may culminate in **diabetes mellitus**. While the pain patterns overlap, chronic disease is distinguished by irreversible structural changes such as fibrosis and calcifications visible on imaging. Prompt medical evaluation is essential. **If you experience sudden, severe abdominal pain, especially with vomiting or fever, seek immediate professional care**, as early intervention can prevent life‑threatening complications. ## History/Background Descriptions of pancreatic inflammation date back to ancient medical texts, but the term “pancreatitis” entered the modern lexicon in the 19th century. In 1862, French surgeon **Rene Laënnec** first linked pancreatic inflammation to abdominal pain, and by the early 1900s, physicians recognized the condition’s association with gallstones and alcohol abuse. The 1950s brought the first systematic classification of **acute** versus **chronic** forms, while the 1970s saw the introduction of the **Ranson criteria**, a scoring system to predict severity in acute cases. Advances in imaging—ultrasound in the 1970s, computed tomography (CT) in the 1980s, and magnetic resonance cholangiopancreatography (MRCP) in the 1990s—revolutionized diagnosis, allowing clinicians to visualize pancreatic edema, necrosis, and ductal obstruction with unprecedented clarity. ## Key Information - **Etiology:** The most common triggers are gallstones (≈40 % of acute cases) and chronic heavy alcohol consumption (≈30 %). Other causes include hypertriglyceridemia, certain medications, traumatic injury, infections, and genetic mutations (e.g., PRSS1, SPINK1). - **Pathophysiology:** Premature activation of digestive enzymes within acinar cells initiates a cascade of inflammation, vascular leakage, and cellular death. In chronic disease, repeated injury leads to fibrosis, calcification, and loss of both exocrine and endocrine tissue. - **Clinical Presentation:** Acute pancreatitis typically presents with sudden, severe epigastric pain radiating to the back, accompanied by nausea, vomiting, and possible fever. Chronic pancreatitis manifests with persistent pain, steatorrhea (fatty stools), weight loss, and eventually **diabetes mellitus** due to β‑cell loss. - **Diagnosis:** Laboratory tests show elevated serum amylase and lipase (often >3× normal). Imaging—abdominal ultrasound for gallstones, contrast‑enhanced CT for necrosis, and MRCP for ductal anatomy—confirms the diagnosis and assesses severity. - **Management:** Acute cases require aggressive fluid resuscitation, pain control, and bowel rest; severe forms may need intensive care, antibiotics for infected necrosis, or endoscopic/ surgical drainage. Chronic pancreatitis management focuses on pain relief, pancreatic enzyme replacement, nutritional support, and strict abstinence from alcohol and smoking. - **Complications:** Include pancreatic pseudocysts, necrotizing infection, hemorrhage, systemic inflammatory response syndrome (SIRS), **diabetes mellitus**, and malnutrition. Early recognition and multidisciplinary care reduce mortality, which remains around 5 % for mild acute disease but can exceed 30 % in severe necrotizing forms. ## Significance Pancreatitis is a leading cause of gastrointestinal hospitalization worldwide, imposing a substantial burden on health systems. Its acute form is the most common gastrointestinal reason for intensive care admission, while chronic pancreatitis contributes to long‑term disability, nutritional deficiencies, and the development of **diabetes mellitus**, a major public health challenge. Understanding risk factors—particularly modifiable ones like alcohol use and gallstone disease—has driven preventive strategies, including public health campaigns on responsible drinking and early cholecystectomy for symptomatic gallstones. Moreover, research into the molecular triggers of enzyme activation has spurred novel therapeutic avenues, such as protease inhibitors and anti‑inflammatory agents, offering hope for disease‑modifying treatments beyond supportive care. The condition’s complexity underscores the need for coordinated care among gastroenterologists, surgeons, radiologists, nutritionists, and primary‑care providers. **INFOBOX:** - Name: Pancreatitis - Type: Inflammatory disease of the pancreas (gastrointestinal) - Date: First modern description – 1862 (Rene Laënnec) - Location: Pancreas (retroperitoneal organ behind the stomach) - Known For: Acute and chronic inflammation leading to severe abdominal pain, organ dysfunction, and potential progression to diabetes mellitus **TAGS:** pancreas, inflammation, acute pancreatitis, chronic pancreatitis, gastrointestinal disease, diabetes mellitus, abdominal pain, gastroenterology
Health & MedicineConditions Encyclopedia Entry 1775628244
This article provides an in-depth look at **Diabetes Mellitus**, a chronic metabolic disorder characterized by high blood sugar levels, its history, key information, significance, and importance of seeking professional care for proper management and treatment.
Health & MedicineInsulin Therapy
** Insulin therapy is the medical use of insulin to control blood glucose levels in people with diabetes mellitus and certain other metabolic disorders. **CONTENT:** ## Overview Insulin therapy involves the administration of **insulin**, a peptide hormone produced by the pancreatic β‑cells, to replace or supplement the body’s own insulin when it is deficient or ineffective. The primary goal is to maintain blood glucose within a target range (typically 70–130 mg/dL fasting) and to prevent both acute complications such as hypoglycemia and hyperglycemia, and long‑term micro‑ and macrovascular damage. Modern regimens may use rapid‑acting, short‑acting, intermediate‑acting, long‑acting, or premixed insulin formulations, delivered via syringes, insulin pens, or continuous subcutaneous insulin infusion (CSII) pumps. Patients with **type 1 diabetes** (absolute insulin deficiency) require lifelong insulin, while many with **type 2 diabetes** eventually need it when oral agents and lifestyle changes no longer achieve glycemic goals. Insulin therapy is also employed in gestational diabetes, cystic fibrosis–related diabetes, and rare conditions such as insulinoma resection. Proper dosing is individualized, based on factors like body weight, carbohydrate intake, physical activity, renal function, and concurrent medications. **Self‑monitoring of blood glucose (SMBG)** or continuous glucose monitoring (CGM) guides dose adjustments and helps prevent dangerous lows. **Important:** If you experience symptoms of severe hypoglycemia (confusion, seizures, loss of consciousness) or hyperglycemia (persistent thirst, frequent urination, nausea, fruity breath), seek immediate medical attention. Always discuss any changes in insulin type, dose, or schedule with a qualified health professional. ## History/Background The story of insulin therapy began in **1921** when Frederick G. Banting and Charles H. Best isolated pancreatic extracts that lowered blood sugar in diabetic dogs. In **1922**, the first successful human injection was given to 14‑year‑old Leonard Thompson, marking the birth of modern diabetes treatment. The Nobel Prize in Physiology or Medicine was awarded to Banting and John J. Macleod in **1923** for this breakthrough. Early insulin was derived from bovine and porcine pancreas, requiring large doses and causing allergic reactions. The **1950s** saw the development of **human insulin** through recombinant DNA technology, first marketed as **Humulin** in **1982**, dramatically improving purity and reducing immunogenicity. Subsequent advances produced **rapid‑acting analogues** (lispro, aspart, glulisine) in the **1990s**, and **long‑acting basal analogues** (glargine, detemir, degludec) in the 2000s, allowing more physiologic mimicking of endogenous insulin secretion. The turn of the millennium introduced **insulin pens**, simplifying dose delivery, and **continuous subcutaneous insulin infusion (CSII) pumps**, which provide programmable basal rates and bolus dosing. More recently, **closed‑loop “artificial pancreas” systems** integrate CGM data with pump algorithms to automatically adjust insulin delivery, representing a paradigm shift toward automated glucose control. ## Key Information - **Types of insulin** - *Rapid‑acting* (e.g., insulin lispro): onset 10–30 min, peak 1–2 h, duration 3–5 h. - *Short‑acting* (regular insulin): onset 30–60 min, peak 2–4 h, duration 6–8 h. - *Intermediate‑acting* (NPH): onset 1–2 h, peak 4–12 h, duration 12–18 h. - *Long‑acting* (glargine, detemir, degludec): onset 1–4 h, minimal peak, duration up to 24 h (degludec up to 42 h). - *Premixed* (70/30, 75/25): combines basal and bolus components for convenience. - **Dosing strategies** - *Basal‑bolus* regimen: separate basal insulin for background needs plus bolus doses for meals. - *Fixed‑ratio* (e.g., 70/30) or *split‑dose* regimens for patients preferring fewer injections. - *Pump therapy*: delivers continuous basal infusion with on‑demand boluses. - **Monitoring** - SMBG: 4–6 checks daily for most regimens. - CGM: provides real‑time glucose trends, alerts for hypo‑ and hyperglycemia, and data for dose refinement. - **Adverse effects** - *Hypoglycemia*: most common acute risk; symptoms range from shakiness to seizures. - *Weight gain*: due to anabolic effects of insulin. - *Injection site reactions*: lipohypertrophy can impair absorption. - Rare allergic reactions to insulin or excipients. - **Special considerations** - Adjust doses during illness, exercise, or steroid therapy. - Renal or hepatic impairment may prolong insulin action. - Pregnancy: tighter glycemic targets; rapid‑acting analogues are generally considered safe. ## Significance Insulin therapy transformed diabetes from a uniformly fatal disease into a manageable chronic condition, dramatically extending life expectancy and quality of life. It underpins modern diabetes care, enabling individuals to pursue education, careers, and family life with minimal restriction. Economically, effective insulin use reduces costly complications such as dialysis, blindness, and cardiovascular events, lessening the burden on health systems worldwide. The evolution toward **physiologic insulin analogues** and **automated delivery systems** reflects a broader trend of personalized medicine, where therapy is tailored to each person’s lifestyle, physiology, and preferences. Ongoing research into ultra‑rapid formulations, smart insulin that responds to glucose levels, and fully closed‑loop systems promises even tighter control with fewer user interventions. Nevertheless, access to affordable insulin remains a global challenge; disparities in availability contribute to preventable morbidity and mortality, especially in low‑ and middle‑income countries. Advocacy for equitable pricing, transparent supply chains, and robust patient education is essential to ensure that the life‑saving benefits of insulin therapy reach every person who needs it. **INFOBOX:** - **Name:** Insulin Therapy - **Type:** Medical treatment for diabetes mellitus and related metabolic disorders - **Date:** Initiated 1922 (first human use) – continuously evolving - **Location:** Worldwide; administered in clinical, home, and community settings - **Known For:** Replacing deficient insulin to regulate blood glucose and prevent diabetic complications **TAGS:** insulin, diabetes mellitus, endocrine therapy, glucose monitoring, insulin analogues, continuous subcutaneous insulin infusion, artificial pancreas, hypoglycemia prevention
Health & MedicineConditions Encyclopedia Entry 1775797509
This article provides an in-depth look at **Diabetes Mellitus**, a chronic metabolic disorder characterized by high blood sugar levels, its history, key information, significance, and importance of seeking professional care for proper management and treatment.
Health & MedicineConditions Encyclopedia Entry 1777886525
This encyclopedia entry provides an in-depth look at **Diabetes Mellitus**, a chronic metabolic disorder characterized by high blood sugar levels, and its various aspects, including history, types, symptoms, diagnosis, treatment, and management.
Health & MedicineConditions Encyclopedia Entry 1776830525
This article provides an in-depth look at **Diabetes Mellitus**, a chronic metabolic disorder characterized by high blood sugar levels, its history, key information, significance, and importance of seeking professional care for proper management and treatment.
Health & MedicineConditions Encyclopedia Entry 1779106624
This encyclopedia entry provides an in-depth look at **Diabetes Mellitus**, a chronic metabolic disorder characterized by high blood sugar levels, its history, key information, significance, and importance of seeking professional care for proper management and treatment.
Health & MedicineConditions Encyclopedia Entry 1777953664
This encyclopedia entry provides an in-depth look at **Diabetes Mellitus**, a chronic metabolic disorder characterized by high blood sugar levels, its history, key information, significance, and importance of seeking professional care for proper management and treatment.
Health & MedicineConditions Encyclopedia Entry 1778187485
This article provides an in-depth look at **Diabetes Mellitus**, a chronic metabolic disorder characterized by high blood sugar levels, its history, key information, significance, and importance of seeking professional care for proper management.
Health & MedicineConditions Encyclopedia Entry 1782495425
This article provides an in-depth examination of **Diabetes Mellitus**, a chronic metabolic disorder characterized by high blood sugar levels, its history, key information, significance, and importance of seeking professional care.
Health & MedicineConditions Encyclopedia Entry 1780252941
This article provides an in-depth look at **Diabetes Mellitus**, a chronic metabolic disorder characterized by high blood sugar levels, its history, key information, significance, and importance of seeking professional care for proper management and treatment.
Health & MedicineConditions Encyclopedia Entry 1783047125
This article provides an in-depth exploration of **Diabetes Mellitus**, a chronic metabolic disorder characterized by high blood sugar levels, its history, key information, significance, and importance of seeking professional care for management and treatment.
Health & MedicineConditions Encyclopedia Entry 1782841626
This article provides an in-depth examination of **Diabetes Mellitus**, a chronic metabolic disorder characterized by high blood sugar levels, its history, key information, significance, and importance of seeking professional care for management and treatment.